MEDNOW INC-A (MNOW.CA) Fundamental Analysis & Valuation

TSX-V:MNOW • CA58503L2021

Current stock price

0.02 CAD
-0.04 (-63.64%)
Last:

This MNOW.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. MNOW.CA Profitability Analysis

1.1 Basic Checks

  • MNOW had negative earnings in the past year.
  • MNOW had a negative operating cash flow in the past year.
MNOW.CA Yearly Net Income VS EBIT VS OCF VS FCFMNOW.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 -5M -10M -15M -20M -25M

1.2 Ratios

Industry RankSector Rank
ROA -195.36%
ROE N/A
ROIC N/A
ROA(3y)-65.76%
ROA(5y)-2284.76%
ROE(3y)-173.67%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MNOW.CA Yearly ROA, ROE, ROICMNOW.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 0 -2K -4K -6K -8K -10K

1.3 Margins

  • The Profit Margin and Operating Margin are not available for MNOW so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 13.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MNOW.CA Yearly Profit, Operating, Gross MarginsMNOW.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 0 -500 -1K -1.5K -2K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. MNOW.CA Health Analysis

2.1 Basic Checks

  • MNOW does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • MNOW has about the same amout of shares outstanding than it did 1 year ago.
  • The debt/assets ratio for MNOW is higher compared to a year ago.
MNOW.CA Yearly Shares OutstandingMNOW.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 5M 10M 15M 20M
MNOW.CA Yearly Total Debt VS Total AssetsMNOW.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of -6.08, we must say that MNOW is in the distress zone and has some risk of bankruptcy.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6.08
ROIC/WACCN/A
WACC4.05%
MNOW.CA Yearly LT Debt VS Equity VS FCFMNOW.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 10M -10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 0.41 indicates that MNOW may have some problems paying its short term obligations.
  • MNOW has a Quick Ratio of 0.41. This is a bad value and indicates that MNOW is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.41
Quick Ratio 0.32
MNOW.CA Yearly Current Assets VS Current LiabilitesMNOW.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. MNOW.CA Growth Analysis

3.1 Past

  • The earnings per share for MNOW have decreased by -1.69% in the last year.
  • MNOW shows a strong growth in Revenue. In the last year, the Revenue has grown by 1100.55%.
EPS 1Y (TTM)-1.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.37%
Revenue 1Y (TTM)1100.55%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%466.23%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MNOW.CA Yearly Revenue VS EstimatesMNOW.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 5M 10M 15M

More info and screens

Find the best growth stocksShow best growing peers

0

4. MNOW.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MNOW. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MNOW.CA Price Earnings VS Forward Price EarningsMNOW.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MNOW.CA Per share dataMNOW.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MNOW.CA Dividend Analysis

5.1 Amount

  • MNOW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

MNOW.CA Fundamentals: All Metrics, Ratios and Statistics

MEDNOW INC-A

TSX-V:MNOW (11/2/2023, 7:00:00 PM)

0.02

-0.04 (-63.64%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap297.29K
Revenue(TTM)35.25M
Net Income(TTM)-27.71M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.28
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.11
FCFYN/A
OCF(TTM)-0.96
OCFYN/A
SpS2.37
BVpS-0.13
TBVpS-0.31
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -195.36%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 13.18%
FCFM N/A
ROA(3y)-65.76%
ROA(5y)-2284.76%
ROE(3y)-173.67%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover2.48
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 81.26%
Cap/Sales 6.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.41
Quick Ratio 0.32
Altman-Z -6.08
F-Score3
WACC4.05%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.37%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1100.55%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%466.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-611.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-626.99%
OCF growth 3YN/A
OCF growth 5YN/A

MEDNOW INC-A / MNOW.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MEDNOW INC-A?

ChartMill assigns a fundamental rating of 0 / 10 to MNOW.CA.


What is the valuation status for MNOW stock?

ChartMill assigns a valuation rating of 0 / 10 to MEDNOW INC-A (MNOW.CA). This can be considered as Overvalued.


How profitable is MEDNOW INC-A (MNOW.CA) stock?

MEDNOW INC-A (MNOW.CA) has a profitability rating of 0 / 10.